Regeneron Pharmaceuticals, Inc.

Schonfeld Strategic Advisors LLC REGN

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/14/2025

Shares

2,634

Value ($000)

1,481

Weight

0.0%

2020 Q1 - 2025 Q3 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/14/2025	1,481	0.0%	2,634	9/30/2025
2025 Q1	5/15/2025	4,998	0.0%	7,880	3/31/2025
2024 Q4	2/14/2025	15,948	0.1%	22,388	12/31/2024
2024 Q3	11/14/2024	4,091	0.0%	3,892	9/30/2024
2024 Q2	8/14/2024	1,471	0.0%	1,400	6/30/2024
2023 Q4	2/14/2024	1,317	0.0%	1,500	12/31/2023
2023 Q3	11/14/2023	3,321	0.0%	4,035	9/30/2023
2023 Q2	8/14/2023	652	0.0%	908	6/30/2023
2023 Q1	5/15/2023	2,981	0.0%	3,628	3/31/2023
2022 Q3	11/14/2022	3,707	0.0%	5,380	9/30/2022
2022 Q2	8/15/2022	8,146	0.1%	13,780	6/30/2022
2022 Q1	5/16/2022	881	0.0%	1,261	3/31/2022
2021 Q3	11/16/2021	1,054	0.0%	1,741	9/30/2021
2021 Q2	11/16/2021	10,709	0.1%	19,173	6/30/2021
2021 Q1	5/17/2021	4,510	0.1%	9,535	3/31/2021
2020 Q4	2/16/2021	773	0.0%	1,600	12/31/2020
2020 Q1	5/15/2020	1,198	0.1%	2,454	3/31/2020